UK markets close in 30 minutes

GlaxoSmithKline plc (GLAXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
17.77-0.63 (-3.42%)
As of 10:14AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 76.13B
Enterprise value 94.12B
Trailing P/E 9.77
Forward P/E 9.19
PEG ratio (5-yr expected) 0.97
Price/sales (ttm)2.00
Price/book (mrq)4.54
Enterprise value/revenue 3.17
Enterprise value/EBITDA 9.78

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 3-2.39%
S&P500 52-week change 315.95%
52-week high 319.60
52-week low 316.34
50-day moving average 317.76
200-day moving average 317.67

Share statistics

Avg vol (3-month) 31.51k
Avg vol (10-day) 31.13k
Shares outstanding 54.12B
Implied shares outstanding 64.11B
Float 83.93B
% held by insiders 11.74%
% held by institutions 145.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.7
Forward annual dividend yield 43.78%
Trailing annual dividend rate 30.56
Trailing annual dividend yield 33.03%
5-year average dividend yield 45.13
Payout ratio 437.47%
Dividend date 309 Jan 2019
Ex-dividend date 415 Nov 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023

Profitability

Profit margin 20.48%
Operating margin (ttm)31.37%

Management effectiveness

Return on assets (ttm)7.90%
Return on equity (ttm)61.26%

Income statement

Revenue (ttm)29.65B
Revenue per share (ttm)7.33
Quarterly revenue growth (yoy)4.10%
Gross profit (ttm)19.92B
EBITDA 9.19B
Net income avi to common (ttm)6.08B
Diluted EPS (ttm)1.88
Quarterly earnings growth (yoy)-86.50%

Balance sheet

Total cash (mrq)6.68B
Total cash per share (mrq)1.65
Total debt (mrq)20.84B
Total debt/equity (mrq)165.16%
Current ratio (mrq)0.95
Book value per share (mrq)3.24

Cash flow statement

Operating cash flow (ttm)5.48B
Levered free cash flow (ttm)1.86B